Channing Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-145,217
| Closed | -$10.3M | – | 110 |
|
|
2022
Q3 | $10.3M | Buy |
145,217
+18,693
| +15% | +$1.33M | 0.36% | 59 |
|
|
2022
Q2 | $9.74M | Sell |
126,524
-26,366
| -17% | -$2.03M | 0.32% | 67 |
|
|
2022
Q1 | $11.2M | Sell |
152,890
-22,812
| -13% | -$1.67M | 0.33% | 68 |
|
|
2021
Q4 | $11M | Buy |
175,702
+159
| +0.1% | +$9.91K | 0.31% | 77 |
|
|
2021
Q3 | $10.4M | Buy |
175,543
+9,976
| +6% | +$590K | 0.32% | 80 |
|
|
2021
Q2 | $11.1M | Buy |
165,567
+38,011
| +30% | +$2.54M | 0.36% | 84 |
|
|
2021
Q1 | $8.05M | Buy |
127,556
+10,598
| +9% | +$669K | 0.27% | 92 |
|
|
2020
Q4 | $7.26M | Buy |
116,958
+30,907
| +36% | +$1.92M | 0.3% | 87 |
|
|
2020
Q3 | $5.19M | Sell |
86,051
-3,931
| -4% | -$237K | 0.28% | 90 |
|
|
2020
Q2 | $5.29M | Sell |
89,982
-10,999
| -11% | -$647K | 0.3% | 87 |
|
|
2020
Q1 | $5.63M | Sell |
100,981
-31,095
| -24% | -$1.73M | 0.4% | 63 |
|
|
2019
Q4 | $8.48M | Sell |
132,076
-56,358
| -30% | -$3.62M | 0.39% | 74 |
|
|
2019
Q3 | $9.56M | Buy |
188,434
+10,512
| +6% | +$533K | 0.44% | 60 |
|
|
2019
Q2 | $8.07M | Buy |
177,922
+38,938
| +28% | +$1.77M | 0.37% | 68 |
|
|
2019
Q1 | $6.63M | Sell |
138,984
-19,765
| -12% | -$943K | 0.31% | 77 |
|
|
2018
Q4 | $8.25M | Sell |
158,749
-6,631
| -4% | -$345K | 0.41% | 58 |
|
|
2018
Q3 | $10.3M | Buy |
165,380
+1,866
| +1% | +$116K | 0.37% | 53 |
|
|
2018
Q2 | $9.05M | Buy |
163,514
+77,691
| +91% | +$4.3M | 0.32% | 71 |
|
|
2018
Q1 | $5.43M | Buy |
85,823
+122
| +0.1% | +$7.72K | 0.19% | 88 |
|
|
2017
Q4 | $5.25M | Hold |
85,701
| – | – | 0.18% | 92 |
|
|
2017
Q3 | $5.46M | Buy |
+85,701
| New | +$5.46M | 0.21% | 89 |
|